Close Menu
New York Examiner News

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    Are You Under Attack By Howard Bloom

    November 20, 2026

    The Odysseys Blu-ray Is Missing One Major Extra, But Christopher Nolan Has A Good Reason

    November 20, 2026

    The Traitors: New Blood: Jay Vinnedge on Being the King of Chaos & His Supsicions of Katie

    November 20, 2026
    Facebook X (Twitter) Instagram
    New York Examiner News
    • Home
    • US News
    • Politics
    • Business
    • Science
    • Technology
    • Lifestyle
    • Music
    • Television
    • Film
    • Books
    • Contact
      • About
      • Amazon Disclaimer
      • DMCA / Copyrights Disclaimer
      • Terms and Conditions
      • Privacy Policy
    New York Examiner News
    Home»Science»Crispr Offers New Hope for Treating Diabetes
    Science

    Crispr Offers New Hope for Treating Diabetes

    By AdminSeptember 11, 2025
    Facebook Twitter Pinterest LinkedIn WhatsApp Email Reddit Telegram
    Crispr Offers New Hope for Treating Diabetes

    [ad_1]

    Crispr gene-editing technology has demonstrated its revolutionary potential in recent years: It has been used to treat rare diseases, to adapt crops to withstand the extremes of climate change, or even to change the color of a spider’s web. But the greatest hope is that this technology will help find a cure for a global disease, such as diabetes. A new study points in that direction.

    For the first time, researchers succeeded in implanting Crispr-edited pancreatic cells in a man with type 1 diabetes, an autoimmune disease where the immune system attacks insulin-producing cells in the pancreas. Without insulin, the body is then unable to regulate blood sugar. If steps aren’t taken to manage glucose levels by other means (typically, by injecting insulin), this can lead to damage to the nerves and organs—particularly the heart, kidneys, and eyes. Roughly 9.5 million people worldwide have type 1 diabetes.

    In this experiment, edited cells produced insulin for months after being implanted, without the need for the recipient to take any immunosuppressive drugs to stop their body attacking the cells. The Crispr technology allowed the researchers to endow the genetically modified cells with camouflage to evade detection.

    The study, published last month in The New England Journal of Medicine, details the step-by-step procedure. First, pancreatic islet cells were taken from a deceased donor without diabetes, and then altered with the gene-editing technique Crispr-Cas12b to allow them to evade the immune response of the diabetes patient. Cells altered like this are said to be “hypoimmune,” explains Sonja Schrepfer, a professor at Cedars-Sinai Medical Center in California and the scientific cofounder of Sana Biotechnology, the company that developed this treatment.

    The edited cells were then implanted into the forearm muscle of the patient, and after 12 weeks, no signs of rejection were detected. (A subsequent report from Sana Biotechnology notes that the implanted cells were still evading the patient’s immune system after six months.)

    Tests run as part of the study recorded that the cells were functional: The implanted cells secreted insulin in response to glucose levels, representing a key step toward controlling diabetes without the need for insulin injections. Four adverse events were recorded during follow-ups with the patient, but none of them were serious or directly linked to the modified cells.

    The researchers’ ultimate goal is to apply immune-camouflaging gene edits to stem cells—which have the ability to reproduce and differentiate themselves into other cell types inside the body—and then to direct their development into insulin-secreting islet cells. “The advantage of engineering hypoimmune stem cells is that when these stem cells proliferate and create new cells, the new cells are also hypoimmune,” Schrepfer explained in a Cedars-Sinai Q+A earlier this year.

    Traditionally, transplanting foreign cells into a patient has required suppressing the patient’s immune system to avoid them being rejected. This carries significant risks: infections, toxicity, and long-term complications. “Seeing patients die from rejection or severe complications from immunosuppression was frustrating to me, and I decided to focus my career on developing strategies to overcome immune rejection without immunosuppressive drugs,” Schrepfer told Cedars-Sinai.

    Although the research marks a milestone in the search for treatments of type 1 diabetes, it’s important to note that the study involved one one participant, who received a low dose of cells for a short period—not enough for the patient to no longer need to control their blood sugar with injected insulin. An editorial by the journal Nature also says that some independent research groups have failed in their efforts to confirm that Sana’s method provides edited cells with the ability to evade the immune system.

    Sana will be looking to conduct more clinical trials starting next year. Without overlooking the criticisms and limitations of the current study, the possibility of transplanting cells modified to be invisible to the immune system opens up a very promising horizon in regenerative medicine.

    This story originally appeared on WIRED en Español and has been translated from Spanish.

    [ad_2]

    Original Source Link

    Share. Facebook Twitter Pinterest LinkedIn WhatsApp Email Reddit Telegram
    Previous ArticleMcDonald’s Releases New Cinnamoroll and Kuromi Happy Meals
    Next Article DreamCloud Hybrid Mattress Review: Support and Value

    RELATED POSTS

    Climate Change Has Pushed the World's Ice Out of Its Safe Zone

    November 12, 2026

    Synchron Pauses Trials of Its Brain Implant Due to Performance Issues

    November 12, 2026

    The Polar Vortex Is About to Make Weather Weird From the UK to the US

    November 12, 2026

    A Startup Wants to Fight AI Bioweapons With AI

    November 11, 2026

    Michigan Residents Voted to Get Corporate Money Out of Politics. Now Utilities Are Suing

    November 11, 2026

    A New Benchmark for De-Aging Comes From Slowly Turning Back Cells Clocks

    November 11, 2026
    latest posts

    Are You Under Attack By Howard Bloom

    This has been a big six weeks for what looks like sabotage. It started with…

    The Odysseys Blu-ray Is Missing One Major Extra, But Christopher Nolan Has A Good Reason

    November 20, 2026

    The Traitors: New Blood: Jay Vinnedge on Being the King of Chaos & His Supsicions of Katie

    November 20, 2026

    Chvrches share tongue-in-cheek new single Evil and announce UK album launch shows in churches

    November 19, 2026

    Fantasy and Science Fiction Books Where the Rules Dont Apply – NewInBooks

    November 19, 2026

    Power Trip Unveil New Song Mutual Death Warrant via GTA 6

    November 19, 2026

    Anthropics IPO puts AIs circular financing boom to the test | TechCrunch

    November 19, 2026
    Categories
    • Books (1,593)
    • Business (6,481)
    • Events (85)
    • Film (6,456)
    • Lifestyle (4,505)
    • Music (6,590)
    • Politics (6,448)
    • Science (5,858)
    • Technology (6,446)
    • Television (6,149)
    • US News (6,491)
    popular posts

    Sen. Reuben Gallego Calls For Eric Swalwell To Be Expelled From Congress

    [ad_1] As more women come forward alleging a wide scope of sexual misconduct was committed…

    Designer Donna Leah Talks About Mood Enhancing Colors For Spring Fashion

    February 25, 2024

    Startups Weekly: Drama at Techstars. Drama in AI. Drama everywhere.

    May 25, 2024

    While the COVID Virus Mostly Spared Children, Dr. Fauci Did Not… EVIL Dr. Fauci Killed from 300,000 to 900,000 Children with His Lockdowns, Mostly in Africa

    June 20, 2022
    Archives
    Browse By Category
    • Books (1,593)
    • Business (6,481)
    • Events (85)
    • Film (6,456)
    • Lifestyle (4,505)
    • Music (6,590)
    • Politics (6,448)
    • Science (5,858)
    • Technology (6,446)
    • Television (6,149)
    • US News (6,491)
    About Us

    We are a creativity led international team with a digital soul. Our work is a custom built by the storytellers and strategists with a flair for exploiting the latest advancements in media and technology.

    Most of all, we stand behind our ideas and believe in creativity as the most powerful force in business.

    What makes us Different

    We care. We collaborate. We do great work. And we do it with a smile, because we’re pretty damn excited to do what we do. If you would like details on what else we can do visit out Contact page.

    Our Picks

    Power Trip Unveil New Song Mutual Death Warrant via GTA 6

    November 19, 2026

    Anthropics IPO puts AIs circular financing boom to the test | TechCrunch

    November 19, 2026

    Jax Taylor Reveals Cancer Diagnosis, Has Major Surgery

    November 19, 2026
    © 2026 New York Examiner News. All rights reserved. All articles, images, product names, logos, and brands are property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Terms & Conditions and Privacy Policy.

    Type above and press Enter to search. Press Esc to cancel.

    We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
    Cookie SettingsAccept All
    Manage consent

    Privacy Overview

    This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
    Necessary
    Always Enabled
    Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
    CookieDurationDescription
    cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
    cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
    cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
    cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
    cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
    viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
    Functional
    Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
    Performance
    Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
    Analytics
    Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
    Advertisement
    Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
    Others
    Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
    SAVE & ACCEPT